Tectonic Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
16,007
-1,327
-8% -$90.5K 0.06% 163
2026
Q1
$1.12M Buy
17,334
+103
+0.6% +$7.26K 0.06% 156
2025
Q4
$1.16M Buy
17,231
+667
+4% +$44.9K 0.06% 154
2025
Q3
$1.21M Sell
16,564
-8,727
-35% -$580K 0.07% 157
2025
Q2
$1.32M Sell
25,291
-5,268
-17% -$300K 0.08% 138
2025
Q1
$1.95M Buy
30,559
+6,438
+27% +$374K 0.12% 103
2024
Q4
$1.15M Sell
24,121
-1,292
-5% -$66.3K 0.08% 139
2024
Q3
$1.45M Sell
25,413
-3,702
-13% -$212K 0.1% 119
2024
Q2
$1.52M Buy
29,115
+10,874
+60% +$477K 0.11% 108
2024
Q1
$742K Buy
+18,241
New +$684K 0.06% 184

Other funds holding HALO

Tectonic Advisors's HALO Position: Q2 2026 in Review

Tectonic Advisors reduced its Halozyme (HALO) stake by 7.7% in Q2 2026, selling an estimated $90.5K and leaving 16,007 shares worth $1.25M. The position accounts for 0.06% of the portfolio, ranked #163.

Tectonic Advisors first reported a position in HALO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.95M in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Tectonic Advisors held 16,007 shares of Halozyme worth $1.25M as of Q2 2026.
  • Tectonic Advisors sold 1,327 Halozyme shares in Q2 2026, an estimated $90.5K.
  • Halozyme made up 0.06% of Tectonic Advisors's portfolio in Q2 2026, its #163 holding.
  • Tectonic Advisors first reported a position in Halozyme in Q1 2024 and has held it in 10 quarters since.
  • Tectonic Advisors's Halozyme position peaked at $1.95M in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Tectonic Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.